XML 86 R71.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Jan. 29, 2022
Jan. 30, 2021
Feb. 01, 2020
Stock-based compensation expense      
Number of shares available for future issuance under the plan 8,726,638    
Total stock-based compensation expense $ 52,800 $ 50,177 $ 43,493
Total related tax benefit 9,927 10,443 9,620
Stock options      
Stock-based compensation expense      
Stock-based compensation expense $ 5,338 $ 6,186 $ 6,286
Vesting rights (as a percent) 25.00%    
Vesting period 4 years    
Expiration terms of options 7 years    
Weighted average assumptions used to estimate the fair value of stock-based awards to employees      
Exercise price (in dollars per share) $ 72.40 $ 17.80 $ 38.58
Expected term (in years) 4 years 9 months 18 days 5 years 6 months 21 days 5 years 4 months 20 days
Weighted average volatility (as a percent) 47.97% 41.31% 35.75%
Risk-free interest rate (as a percent) 0.73% 0.78% 2.05%
Expected dividend yield (as a percent) 2.00% 6.27% 2.77%
Weighted average grant date fair value (in dollars per share) $ 25.20 $ 3.70 $ 10.59
Shares Subject to Options      
Outstanding at the beginning of the period (in shares) 4,352,896    
Granted (in shares) 1,488    
Exercised (in shares) (657,234)    
Forfeited / Expired (in shares) (22,378)    
Outstanding at the end of the period (in shares) 3,674,772 4,352,896  
Exercisable at the end of the period (in shares) 1,480,866    
Vested and expected to vest at the end of the period (in shares) 3,514,737    
Weighted Average Exercise Price per Share      
Outstanding at the beginning of the period (in dollars per share) $ 29.28    
Granted (in dollars per share) 72.40    
Exercised (in dollars per share) 40.09    
Forfeited / Expired (in dollars per share) 19.53    
Outstanding at the end of the period (in dollars per share) 21.78 $ 29.28  
Exercisable at the end of the period (in dollars per share) 30.46    
Vested and expected to vest at the end of the period (in dollars per share) $ 22.03    
Weighted Average Remaining Contractual Life (in years)      
Weighted Average Remaining Contractual Life 4 years 2 months 15 days 4 years 11 months 15 days  
Exercisable at the end of the period 3 years 2 months 4 days    
Vested and expected to vest at the end of the period 4 years 2 months 1 day    
Aggregate Intrinsic Value      
Outstanding at the beginning of the period (in dollars) $ 164,200    
Outstanding at the end of the period (in dollars) 335,900 $ 164,200  
Exercisable at the end of the period (in dollars) 122,500    
Vested and expected to vest at the end of the period (in dollars) 320,400    
Additional disclosures      
Total intrinsic value of stock options exercised 37,100 8,300 $ 1,000
Income tax benefit (expense) from the exercise of stock options 6,800 (600) (200)
Total fair value of stock options vested 6,300 6,100 7,000
Unrecognized compensation expense      
Unrecognized stock-based compensation expense related to nonvested awards, net of estimated forfeitures $ 6,100    
Weighted average period over which unrecognized compensation expense is expected to be recognized 1 year 10 months 24 days    
Restricted stock      
Stock-based compensation expense      
Stock-based compensation expense $ 47,462 $ 43,991 $ 37,207
Vesting period 3 years    
Unrecognized compensation expense      
Unrecognized stock-based compensation expense related to nonvested awards, net of estimated forfeitures $ 58,500    
Weighted average period over which unrecognized compensation expense is expected to be recognized 1 year 1 month 6 days